APPIO THOMAS 4
Research Summary
AI-generated summary
Bausch Health (BHC) CEO Thomas Appio Receives RSU Award; Shares Withheld
What Happened
- Thomas Appio, CEO of Bausch Health Companies Inc. (BHC), received an award of 815,425 restricted share units (RSUs) on 2026-02-25 (reported as an acquisition/award). On 2026-02-26 the filing shows 116,502 shares were disposed to satisfy tax withholding obligations at $6.04 per share, totaling about $703,672.
- The RSUs were granted at $0 acquisition price (standard for RSU awards). The withholding transaction (code F) is a tax-related disposition, not an open-market sale.
Key Details
- Transaction dates: Grant 2026-02-25 (A); tax withholding disposal 2026-02-26 (F).
- Withholding price and value: 116,502 shares × $6.04 = $703,672 (disposed/withheld).
- Vesting schedule (footnote): The awarded RSUs vest one‑third on each of the first three anniversaries after the grant date and will be settled in common shares (footnote F1).
- Withheld shares explanation (footnote F2): 116,502 common shares were withheld to satisfy tax withholding on RSU vesting.
- Shares owned after the transaction: Not stated in the provided filing excerpt.
- Filing timeliness: Report filed 2026-02-27 for transactions on 2026-02-25/26 — appears timely (Form 4 is typically due within two business days).
Context
- RSU awards are compensation-based grants that deliver shares if/when they vest; the tax-withholding disposal is routine and does not necessarily indicate a buy/sell signal by the insider.
- This was not an open-market sale or purchase; the disposed shares were withheld for taxes rather than sold in the market.